Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00689
|
|||||
| Drug Name |
Carvedilol
|
|||||
| Synonyms |
(+-)-1-(Carbazol-4-yloxy)-3-((2-(o-methoxyphenoxy)ethyl)amino)-2-propanol; (+-)-1-Carbazol-4-yloxy)-3-((2-(o-methoxyphenoxy)ethyl)amino)-2-propanol; (+/-)-1-(Carbazol-4-yloxy)-3-[[2-(o-methoxyphenoxy)ethyl]amino]-2-propanol; 1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]-2-propanol; 1-(9H-carbazol-4-yloxy)-3-[(2-{[2-(methyloxy)phenyl]oxy}ethyl)amino]propan-2-ol; 1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol; 1-(9H-carbazol-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino}propan-2-ol; Artist; Artist (TN); Atlana Pharma brand of carvedilol; BM 14190; BM-14-190; BM-14.190; BM-14190; Carloc (TN); Carvedilol (JAN/USAN/INN); Carvedilol [USAN:INN:BAN:JAN]; Carvedilol, (+-)-isomer; Carvedilol, (R)-isomer; Carvedilol, (S)-isomer; Carvedilol, 14C-labeled; Carvedilolum; Carvedilolum [Latin]; Coreg; Coreg (TN); Coreg CR; Coropres; Coropress; DQ 2466; DQ-2466; Dibloc; Dilatrend; Dilatrend (TN); EG-P042; Eucardic; Eucardic (TN); GlaxoSmithKline brand of carvedilol; Kredex; Lakeside brand of carvedilol; Querto; Roche brand of carvedilol; SK&F-105517; SKF 105517
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Congestive heart failure [ICD11: BD10] | Approved | [1] | |||
| Therapeutic Class |
Vasodilator Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C24H26N2O4
|
|||||
| Canonical SMILES |
COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O
|
|||||
| InChI |
InChI=1S/C24H26N2O4/c1-28-21-10-4-5-11-22(21)29-14-13-25-15-17(27)16-30-23-12-6-9-20-24(23)18-7-2-3-8-19(18)26-20/h2-12,17,25-27H,13-16H2,1H3
|
|||||
| InChIKey |
OGHNVEJMJSYVRP-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 72956-09-3
|
|||||
| Pharmaceutical Properties | Molecular Weight | 406.5 | Topological Polar Surface Area | 75.7 | ||
| Heavy Atom Count | 30 | Rotatable Bond Count | 10 | |||
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 5 | |||
| XLogP |
4.2
|
|||||
| PubChem CID | ||||||
| PubChem SID |
103197484
, 11364559
, 11367121
, 11369683
, 11372422
, 11374391
, 11377845
, 11485621
, 11489489
, 11490997
, 11492451
, 11495479
, 11528712
, 12013067
, 14855122
, 26719722
, 26719723
, 29221745
, 46386749
, 46386871
, 46505146
, 47805057
, 48415707
, 49681735
, 49834917
, 50112972
, 50112973
, 53789407
, 56313592
, 56413047
, 56464135
, 57321386
, 7387304
, 76450239
, 7847321
, 7978866
, 81040900
, 81092790
, 8151709
, 85209910
, 85789499
, 85789708
, 87560280
, 90341342
, 9092
, 92251378
, 92307922
, 92308493
, 92308705
, 92711411
|
|||||
| ChEBI ID |
ChEBI:3441
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | Carvedilol was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Tarascon Pocket Pharmacopoeia 2018 Classic Shirt-Pocket Edition. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.